Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q4 2024 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
Haemonetics Corp (HAE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Neo Ivy Capital Renee Yao | 40,780 | $3,374 | 0.66% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.93 | 4,000 | Director | 12,048 | 2020-08-11 | Filing | |
| $35.00 | 60,000 | Officer | 105,867 | 2016-08-04 | Filing | |
| $32.73 | 412 | Officer | 31,522 | 2013-04-30 | Filing | |
| $32.73 | 615 | Officer | 17,279 | 2013-04-30 | Filing | |
| $32.73 | 245 | Officer | 16,751 | 2013-04-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.00 | 79 | Officer | 21,331 | 2024-07-12 | Filing | |
| $90.00 | 2,136 | Officer | 21,410 | 2024-07-11 | Filing | |
| $88.57 | 4,094 | Officer | 31,257 | 2024-05-29 | Filing | |
| $87.86 | 8,896 | Officer | 35,351 | 2024-05-29 | Filing | |
| $87.53 | 8,857 | Officer | 18,196 | 2024-05-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,523,568 | $557,830,300 | 0.13% | |
| 2. | 6,040,017 | $516,481,857 | 0.01% | |
| 3. | 5,406,309 | $462,293,483 | 0.01% | |
| 4. | 3,531,181 | $301,991,184 | 0.26% | |
| 5. | 3,268,083 | $279,453,776 | 0.05% |
News See All
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Haemonetics Corporation (NYSE:HAE) Q3 2024 Earnings Call Transcript
Haemonetics Corporation beats earnings expectations. Reported EPS is $1.04, expectations were $0.97.
Haemonetics Corporation (NYSE:HAE) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by, and welcome to the Second Quarter 2024 Haemonetics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode.
Ken Fisher Portfolio: 15 Biggest Small-Cap Positions
In this article, we will discuss Ken Fisher portfolio: 15 biggest small-cap positions.
Haemonetics Corporation (NYSE:HAE) Q1 2024 Earnings Call Transcript
Operator: Good morning and thank you for standing by. Welcome to the First Quarter 2024 Haemonetics Corporation's Earnings Conference Call. At this time, all participants are in a listen-only mode.
Haemonetics Corporation (NYSE:HAE) Q4 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Fourth Quarter 2023 Haemonetics Corporation's Earnings Conference Call. At this time, all participants are in listen-only mode.
Haemonetics Corporation (NYSE:HAE) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Haemonetics Third Quarter Fiscal '23 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
5 Pro-Life Companies to Invest In
Franco-Nevada Corporation (NYSE:FNV) is a Canadian company that is operating in two segments: Mining and Energy.
Heartland Advisors: "Haemonetics (HAE) is a Recession-Friendly Stock"
Heartland Advisors, an investment management firm, published its “Heartland Value Plus Fund” second-quarter 2022 investor letter – a copy of which can be downloaded here.
Billionaire Hedge Funds
